Barry D. Quart, Director of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $2.7M. The latest trade was on 05/29.

BQ

BQ

Barry D. Quart

Director

Company

Kiniksa Pharmaceuticals International KNSA

First filing

23/01/17

Trades

56 trades

Buys / sales

0 / 11

12-month net buying

−$2.7M

Last trade

05/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	04/28	04/29	13,099 sh	$50.10	$656,259.9	−51.1%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	04/06	04/08	6,901 sh	$50.00	$345,050	−35.5%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	02/10–02/12	02/12	2,800 sh2 trades	$45.00avg.	$126,000	−18.2%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	02/02–02/04	02/04	15,960 sh3 trades	$45.22avg.	$721,634.6	−56.0%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/12/15	25/12/17	20,129 sh	$41.51	$835,554.79	−61.6%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale	25/06/09–25/06/11	25/06/11	27,448 sh3 trades	$30.35avg.	$833,001.36	−68.6%